The global necrotizing ulcerative gingivitis (NUG) treatment market is estimated to grow at a noteworthy CAGR over the forecast period, i.e., 2022 – 2030. The growth of the market can be attributed to the growing cases of necrotizing ulcerative gingivitis or NUG, especially amongst adults. The major causes of NUG include diet high in sugar, alcohol abuse, tobacco consumption in any form, and careless oral hygiene habits. Patients of diabetes are also at high risk of developing necrotizing ulcerative gingivitis. According to the data by the World Health Organization (WHO), diabetes caused 1.5 million deaths in 2019. The disease is characterized by ulcers in gums, and the lining between teeth, along with severe pain, bad breath, and bleeding in gums. Rising cases of oral diseases, and poor oral health are the primary factors estimated to drive the market growth. According to other statistics by the WHO, 3.5 billion people, which is nearly half of the global population, suffer from oral diseases. Almost 10% of the global population experiences gum-related problems, while 530 million children have cavities in their milk teeth. Lack of awareness regarding oral health is another major factor projected to boost the market growth.
Get more information on this report: Download Sample PDF
Consumption of tobacco is a major concern amongst governments of various countries, as well as the health authorities, as tobacco is one of the foremost causes of immature death, and also leads to various severe diseases. According to other report by the WHO, 7 million deaths are caused by direct tobacco consumption, in the form of smoking and chewing tobacco. Various government initiatives to curb the consumption of tobacco, have successfully lowered the share of population consuming tobacco. According to the data by the WHO, 7 million tobacco users increased between 2010 to 2015, while almost 2 million users have decreased between 2018 and 2020. However, tobacco consumption has significantly risen amongst adolescents between the age of 13 to 15 years. This, as a result, is estimated to increase the prevalence of NUG amongst adolescents, which is projected to boost the market growth.
The market is segmented by treatment into medication, and surgery, out of which, the medication segment is anticipated to hold the largest share in the global necrotizing ulcerative gingivitis (NUG) treatment market over the forecast period on account of affordability of medication, and instant relief in symptoms. Moreover, majority cases are diagnosed at a stage where medications can be sufficient for complete treatment of NUG. As the disease is caused by infection, antiseptic, as well as, antibiotic drugs are effective against the symptoms.
According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.
On the basis of geographical analysis, the global necrotizing ulcerative gingivitis (NUG) treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in the North America region is anticipated to gain the largest market share throughout the forecast period owing to the increasing prevalence of oral diseases in the developed countries, including the US, backed by poor diet, and high cases of diabetes amongst the people. According to the data by the Center of Disease Control and Prevention (CDC), more than 1 in every 4 adults, i.e., around 26% of the American population suffers with untreated tooth decay. Moreover, growing health awareness amongst the people and government initiatives to ensure efficient healthcare facilities, are estimated to boost the market growth. Besides this, the rising focus on the advancements in the diagnosis and treatment of different necrotizing gingivostomatitis diseases is also expected to drive the market growth.
The market in Asia Pacific region is estimated to witness noteworthy growth over the forecast period on the back of improving public healthcare system, and growing awareness amongst people regarding oral hygiene.
Get more information on this report: Download Sample PDF
The global necrotizing ulcerative gingivitis (NUG) treatment market is further classified on the basis of region as follows:
Our in-depth analysis of the global necrotizing ulcerative gingivitis (NUG) treatment market includes the following segments:
FREQUENTLY ASKED QUESTIONS
Growing incidences of oral diseases, and poor diet and dental hygiene are estimated to boost the market growth.
The market is anticipated to attain a noteworthy CAGR over the forecast period, i.e., 2022 – 2030.
Lack of health awareness amongst people is estimated to hamper the market growth.
The market in the North America region is estimated to gain most growth opportunities during the forecast period, owing to the high prevalence of oral diseases in the region.
The major players in the market are Mylan N.V., Sanofi S.A., GlaxoSmithKline plc, Merck & Co., Inc., Otsuka Pharmaceutical Co., Ltd., Abbott Laboratories, and others.
The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
The market is segmented by treatment, distribution channel, and others.
The medication segment is anticipated to hold largest market size over the forecast period and display significant growth opportunities.
Select License Type
Direct access to analyst to help you understand the market in a better way to handle your critical question
Citing your business specific requirement our consultant would assist you ensuring targeted goal is achieved
Get 10% free customization